EUVIMEDEUVIMED entdecken
Crossref

Concomitant Mitral Valve Surgery in a Modified Morrow Procedure in Patients with Hypertrophic Obstructive Cardiomyopathy

Chunshui Liang, Mingwen Li, Ruiyan Ma, Zhao Jian

International Heart Journal · 2025

DOI: 10.1536/ihj.24-155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Heart Journal, 2025. Verfasst von Chunshui Liang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Xinqiao Hospital, The Army Medical University. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Mitral Valve Insufficiency, Mitral Valve, Cardiac Surgical Procedures. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ventricular septal myectomy (modified Morrow procedure) is the gold standard surgical intervention for hypertrophic obstructive cardiomyopathy (HOCM). However, the indications for a concomitant mitral valve (MV) procedure to relieve mitral regurgitation (MR) or intrinsic MV pathological changes remain controversial. We aimed to retrospectively analyze this series of patients to evaluate the safety and efficiency of the procedure at our center.We retrospectively reviewed a total of 56 consecutive patients with HOCM who underwent concomitant MV surgery with modified Morrow procedures at our center between January 2019 and December 2021. The baseline characteristics, perioperative data, and postoperative outcomes were examined.The operative mortality rate was 0% among all 56 patients. Two patients had complete atrioventricular block, two patients experienced renal failure, and one patient required reoperation for bleeding. The peak gradient of the left ventricular outflow tract decreased from 93.6 ± 34.4 mm Hg to 20.5 ± 13.0 mm Hg. MR was significantly relieved, and the systolic anterior motion of the MV resolved completely after concomitant MV surgery. During a mean follow-up of 13.8 ± 7.1 months, no patient required cardiac reoperation.Concomitant surgery of the MV during the modified Morrow procedure was performed safely and effectively in the treatment of most types of HOCM in our practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicMitral Valve InsufficiencyMitral ValveCardiac Surgical ProceduresVentricular SeptumHumansMaleFemaleRetrospective StudiesMiddle AgedAdultTreatment OutcomeAged

Stichwörter der Autor:innen

Heart surgical procedureObstructive asymmetric septal hypertrophy

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Xinqiao Hospital, The Army Medical University.

Zitieren

APA

Liang, C., Li, M., Ma, R., & Jian, Z. (2025). Concomitant Mitral Valve Surgery in a Modified Morrow Procedure in Patients with Hypertrophic Obstructive Cardiomyopathy. International Heart Journal. https://doi.org/10.1536/ihj.24-155

Vancouver

Liang C, Li M, Ma R, Jian Z. Concomitant Mitral Valve Surgery in a Modified Morrow Procedure in Patients with Hypertrophic Obstructive Cardiomyopathy. International Heart Journal. 2025. doi:10.1536/ihj.24-155

BibTeX
@article{Liang2025,
  author = {Liang, Chunshui and Li, Mingwen and Ma, Ruiyan and Jian, Zhao},
  title = {Concomitant Mitral Valve Surgery in a Modified Morrow Procedure in Patients with Hypertrophic Obstructive Cardiomyopathy},
  journal = {International Heart Journal},
  year = {2025},
  doi = {10.1536/ihj.24-155}
}
Kostenlos starten →